EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 43 / No 2 (June 2011) J Extra Corpor Technol, 43 2 (2011) 70-74 References
Free Access
Issue
J Extra Corpor Technol
Volume 43, Number 2, June 2011
Page(s) 70 - 74
DOI https://doi.org/10.1051/ject/201143070
Published online 15 June 2011
  1. Centers for Disease Control and Prevention (CDC). Update: Novel influenza A (H1N1) virus infection - Mexico. March–May 2009. MMWR Morb Mortal Wkly Rep. 2009;58:585–9. [Google Scholar]
  2. Lister P, Reynolds F, Parslow R, et al. Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children. Lancet. 2009;374:605–7. [CrossRef] [PubMed] [Google Scholar]
  3. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333–40. [CrossRef] [PubMed] [Google Scholar]
  4. Freed DH, Henzler D, White CW, et al. Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada. Can J Anaesth. 2010;57:240–7. [CrossRef] [PubMed] [Google Scholar]
  5. Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators, Davies A, Jones D, Bailey M, et al. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome. JAMA. 2009;302:1888–95. [CrossRef] [PubMed] [Google Scholar]
  6. Helferty M, Vachon J, Tarasuk J, et al. Incidence of hospital admissions and severe outcomes during the first and second waves of pandemic (H1N1) 2009. CMAJ. 2010;182:1981–7. [CrossRef] [PubMed] [Google Scholar]
  7. Mitchell MD, Mikkelsen ME, Umscheid CA, et al. A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic. Crit Care Med. 2010;38:1398–404. [CrossRef] [PubMed] [Google Scholar]
  8. ECMO registry of the extracorporeal life support organization (ELSO), Ann Arbor, Michigan. Available at: http://www.elso.med.umich.edu Accessed July 1, 2010. [Google Scholar]
  9. Marasco SF, Lukas G, McDonald M, et al. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients. Heart Lung Circ. 2008;17(Suppl 4):S41–7. [CrossRef] [Google Scholar]
  10. Keckler SJ, Laituri CA, Ostlie DJ, St Peter SD. A review of venovenous and venoarterial extracorporeal membrane oxygenation in neonates and children. Eur J Pediatr Surg. 2010;20:1–4. [CrossRef] [PubMed] [Google Scholar]
  11. Pettignano R, Fortenberry JD, Heard ML, et al. Primary use of the venovenous approach for extracorporeal membrane oxygenation in pediatric acute respiratory failure. Pediatr Crit Care Med. 2003;4:291–8. [CrossRef] [PubMed] [Google Scholar]
  12. Brogan TV, Thiagarajan RR, Rycus PT, et al. Extracorporeal membrane oxygenation in adults with severe adult respiratory failure. A multicenter database. Intensive Care Med. 2009;35:2105–14. [CrossRef] [PubMed] [Google Scholar]
  13. Pranikoff T, Hirschl RB, Steinle CN, et al. Mortality is directly related to the duration of mechanical ventilation before the initiation of extracorporeal life support for severe respiratory failure. Crit Care Med. 1997;25:28–32. [CrossRef] [PubMed] [Google Scholar]
  14. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure: A multicenter randomized controlled trial. Lancet. 2009;374:1351–63. [CrossRef] [PubMed] [Google Scholar]
  15. Lapinsky SE. H1N1 novel influenza A in pregnant and immunocompromised patients. Crit Care Med. 2010;38:e52–7. [CrossRef] [PubMed] [Google Scholar]
  16. Hewagama S, Walker SP, Stuart RL, et al. 2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia. Clin Infect Dis. 2010;50:686–90. [CrossRef] [PubMed] [Google Scholar]
  17. Vaillant L, La Ruche G, Tarantola A, Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill. 2009;14:1–6. [CrossRef] [Google Scholar]
  18. Palacios G, Hornig M, Cisterna D, et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS ONE. 2009;4:e8540. [CrossRef] [PubMed] [Google Scholar]
  19. Reed C, Kallen AJ, Patton M, et al. Infection with community-onset staphylococcus aureus and influenza virus in hospitalized children. Pediatr Infect Dis J. 2009;28:572–6. [CrossRef] [PubMed] [Google Scholar]
  20. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness. J Infect Dis. 2008;198:962–70. [CrossRef] [PubMed] [Google Scholar]
  21. Shun-Shin M, Thompson M, Heneghan C, et al. Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: Systematic review and meta-analysis of randomized controlled trials. BMJ. 2009;339:1–9. [Google Scholar]
  22. Goldstein E, Cowling BJ, O’Hagan JJ, et al. Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009. BMC Infect Dis. 2010;10:211–7. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.